Lebanon National Drugs Database

الدليل الوطني للأدوية المسجّلة في لبنان

تحتوي هذه الفقرة على المعلومات الخاصة بالمستحضرات الصيدلانية المسجّلة في وزارة الصحة العامة وهي المرجع الرسمي الوحيد لقاعدة بيانات الأدوية المسموح لتسويقها في لبنان

يمكنكم البحث أدناه عن المعلومات الرسمية للأدوية المسجّلة بالاضافة الى نسبة الدعم

الأدوية التي ليها رمز ينتهي ب "945/" تخضع للقرار رقم 1/945 تاريخ 3/10/2022

...

123

...

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	148,244 L.L
H01CB03	SOMATULINE AUTOGEL	B	Lanreotide (acetate) - 120mg	120mg	Injectable solution	57,492,826 L.L
A10BJ06	OZEMPIC	B	Semaglutide - 0.5mg	0.5mg	Injectable solution	10,927,526 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	148,244 L.L
H01CB05	SIGNIFOR	B	Pasireotide (diaspartate) - 0.3mg/ml	0.3mg/ml	Injectable solution	159,720,381 L.L
A10BJ06	OZEMPIC	B	Semaglutide - 1mg	1mg	Injectable solution	10,927,526 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	159,736 L.L
H01CB05	SIGNIFOR	B	Pasireotide (diaspartate) - 0.6mg/ml	0.6mg/ml	Injectable solution	170,735,579 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	179,272 L.L
H01CB05	SIGNIFOR	B	Pasireotide (diaspartate) - 0.9mg/ml	0.9mg/ml	Injectable solution	174,040,139 L.L
N05AX12	ABILIFY MAINTENA	B	Aripiprazole - 400mg	400mg	Injectable powder for suspension, prolonged release+solvent	29,491,998 L.L
L02AE04	DECAPEPTYL LP	B	Triptorelin (pamoate) - 3mg	3mg	Injectable powder for suspension+diluent	11,778,312 L.L
L02AE04	DECAPEPTYL LP	B	Triptorelin (pamoate) - 11.25mg	11.25mg	Injectable powder for suspension+diluent	31,761,098 L.L
L02AE04	GONAPEPTYL CR	B	Triptorelin - 3.75mg	3.75mg	Injectable powder for suspension+diluent	12,095,730 L.L
H01CB02	SANDOSTATIN LAR	B	Octreotide (acetate) - 20mg	20mg	Injectable powder for suspension+diluent	L.L
H01CB02	SANDOSTATIN LAR	B	Octreotide (acetate) - 30mg	30mg	Injectable powder for suspension+diluent	L.L
L03AX03	BCG-MEDAC	G	BCG seed RIVM derived from seed 1173-P2 - 2x10? to 3x10? viable units		Injectable powder for suspension+diluent	13,873,850 L.L
J07BK01	VARIVAX	B	Varicella virus, live attenuated - 1350PFU		Injectable powder for suspension+diluent	4,102,751 L.L
H01CB02	SANDOSTATIN LAR	B	Octreotide (acetate) - 20mg	20mg	Injectable powder for suspension+diluent	34,573,047 L.L
H01CB02	SANDOSTATIN LAR	B	Octreotide (acetate) - 30mg	30mg	Injectable powder for suspension+diluent	51,860,213 L.L
L01BC07	AZACITIDINE EVER PHARMA	G	Azacitidine - 100mg/100ml	25mg/ml	Injectable powder for suspension	10,967,854 L.L
L01BC07	VAPREZA 100	G	Azacitidine - 100mg	100mg	Injectable powder for suspension	10,706,993 L.L
L01FB01	BESPONSA FOR INJECTION	BioTech	Inotuzumab Ozogamicin - 0.9mg	0.9mg	Injectable powder for suspension	921,176,511 L.L
J01XB01	COLISTIN HIKMA	G	Colistimethate Sodium - 1MIU	1MIU	Injectable powder for solution, Inhalation powder	903,062 L.L
J01XB01	COLISTIMETHATE SODIQUE PANPHARMA	G	Colistimethate Sodium - 1.000.000IU	1.000.000IU	Injectable powder for solution, Inhalation powder	6,392,659 L.L
J01XB01	COLIXIN	G	Colistimethate Sodium - 1,000,000IU	1,000,000IU	Injectable powder for solution, Inhalation powder	20,296,042 L.L
B02BD03	FEIBA	BioHuman	Factor VIII Inhibitor bypassing fraction - 500IU	500U (50U/ml)	Injectable powder for solution+solvent	36,861,820 L.L
B02BD03	FEIBA	BioHuman	Factor VIII Inhibitor bypassing fraction - 1000IU	1000U (50U/ml)	Injectable powder for solution+solvent	72,729,456 L.L
B02BD04	REFIXIA	BioTech	Nonacog beta pegol (factor IX) - 500IU	500IU	Injectable powder for solution+solvent	76,080,435 L.L
B02BD04	REFIXIA	BioTech	Nonacog beta pegol (factor IX) - 1000IU	1000IU	Injectable powder for solution+solvent	135,758,672 L.L

...

123

...